Keywords: synthelabo, eliprodil, fails, stroke, trials, sequential, analysis

Synthelabo's Eliprodil Fails In Stroke Trials

Article | 12 February 1996

Print This

A sequential analysis of the first 483 patients enrolled into a Phase II/III trial of Synthelabo's eliprodil in acute ischemic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in